Skip to main content
. 2019 Feb 3;2019:5729710. doi: 10.1155/2019/5729710

Table 2.

UPR-modulating factors inducing ER stress activity in cancer cells.

Agents Mechanism Cancer type/cell lines References
GSK2606414 and GSK2656157 p-PERK↓, p-elF2α Multiple myeloma [88, 89]
STF-083010 Ire1 inhibitor Multiple myeloma [91]
Sorafenib tyrosine kinase inhibitor (TKI) CHOP↑ GADD34↑; p-PERK↑; p-elF2α L-428, L-1236, and KM-H2 cells [92]
Sal003, inhibitor of phospho-eif2α phosphatase ATF4; p-elF2α Glioblastoma cells [25]
Diindolylmethane derivatives CHOP↑; DR5↑ Pancreatic cancer cells [93]
Bortezomib proteasome inhibitor GRP78↑, CHOP↑, JNK↑, p-eIF2α L3.6pl pancreatic cancer cells [94]
Levistolide A ROS↑; CHOP↑ Colorectal cancer cells [97]
Andrographolide ROS↑; CHOP↑ Colorectal cancer cells [99]
Tolfenamic acid eIF2α↑; ATF4↑ Colorectal cancer cells [98]
Cantharidin GRP78/BiP ↑, IRE1α ↑, IRE1β ↑, ATF6α ↑, XBP1 ↑ H460 [100]
Carnosic acid ROS↑; CHOP↑; ATF4↑ Renal carcinoma Caki cells [101]
Casticin CHOP ↑, p-eIF2α ↑, eIF2α ↑, GRP78/BiP ↑ BGC-823 [102]
Cryptotanshinone p-eIF2α ↑, GRP94 ↑, GRP78 ↑, CHOP ↑, ROS↑ MCF7 [103]
Curcumin CHOP ↑, GRP78/BiP ↑, ROS ↑ NCI-H460, HT-29, AGS [104, 105]
Flavokawain B CHOP ↑, ATF4 ↑ HCT116 [106]
Fucoidan CHOP ↑, ATF4 ↑, p-eIF2α ↑, GRP78/BiP ↓, p-IRE1 ↓, XBP1 ↓ MDA-MB-231 HCT116 [107]
Furanodiene CHOP ↑, BIP ↑ A549, 95-D [108]
2-3,4 Dihydroxyphenylethanol IRE1 ↑, XBP1 ↑, GRP78/BiP ↑, PERK ↑, eIF2α ↑, CHOP ↑ HT-29 [109]
7-Dimethoxyflavone CHOP ↑, GPR78/BiP ↑, ATF4 ↑ Hep3B [110]
SMIP004 (N-(4-butyl-2-methyl-phenyl) acetamide) ROS↑ IRE1↑; p-38↑; p-elF2α Prostate cancer cells [111]
Licochalcone A ATF6 ↑, eIF2α ↑, IRE1α ↑, CHOP ↑, GRP94 ↑, XBP1 ↑, GRP78/BiP ↑ HepG2 [112]
Neferine GRP78/BiP ↑ Hep3B [113]
Paeonol GRP78 ↑, CHOP ↑ HepG2 [114]
Pardaxin ROS↑; p-PERK↑; p-elF2α HeLa cells [115]
Parthenolide ATF4 ↑, p-eIF2a ↑, eIF2α A549, Calu-1, H1299, H1792 [116]
Piperine IRE1α ↑, CHOP ↑, GPR78/BiP ↑ HT-29 [117]
Polyphenon E ATF4 ↑, PERK ↑, p-eIF2α ↑, eIF2α ↑, GRP78/BiP ↑, CHOP ↑, XBP1 ↑, ROS ↑ PC3, PNT1a [118]
Polyphyllin D CHOP ↑, GRP78/BiP ↑, PDI ↑ NCI-H460 [119]
Resveratrol GRP78/BiP ↑, CHOP ↑, XBP1 ↑, eIF2α HT29 [120]
Dehydrocostuslactone p-PERK ↑, GRP78/BiP ↑, IRE1 ↑, CHOP ↑, XBP-1 ↑, ROS ↑ NCI-H460 A549 [121]
γ-Tocotrienol CHOP ↑, GRP78/BiP ↑, XBP1 ↑ MDA-MB-231; MCF-7 [122]
Ω-Hydroxyundec-9-enoic Acid (ω-HUA) ROS↑; CHOP↑ Lung cancer cells (H1299, A549, HCC827) [123]
Ampelopsin ROS↑ GRP78↑; p-PERK↑; p-elF2α Breast cancer cells (MCF-7; MDA-MB-231) [124]
Ardisianone GRP78/BiP ↑ PC3 [125]
Genistein CHOP ↑, GRP78/BiP ↑ Hep3B [126]
Guttiferone H ATF4 ↑, XBP1 ↑, CHOP ↑ HCT116 [127]
Guggulsterone ROS↑; p-eIF2α↑; CHOP↑ DR5↑ Liver cancer cells (Hep3B; HepG2) [128]
Marchantin M GRP78/BiP, CHOP ↑, XBP1 ↑, p-eIF2α ↑, eIF2α ↑, ATF4 ↑, ATF6 ↑, ERAD ↓ PC3, DU145, LNCaP [129]
Sarsasapogenin ROS↑; CHOP↑ HeLa cells [130]
Saxifragifolin IRE1α ↑, XBP1 ↑, CHOP ↑, GRP78/BiP ↑, ROS↑ MDA-MB-231, MCF7 [131]
Prodigiosin ROS↑; CHOP↑; p-eIF2α↑; PERK↑; GRP78↑; ATF6α↑, IRE1 ↑, eIF2a ↑ Pancreatic (8898); breast cancer cells (MCF-7 and MDA-MB-231) [132, 133]
Quercetin GRP78/BiP ↑, ATF4 ↑, IRE1α ↑ ATF6 ↑ PC3 [134]
Honokiol (HNK) ROS↑ p-eIF2α↑; GRP78↑ CHOP↑ Chondrosarcoma (JJ012 and SW1353); gastric (AGS, SCM-1 and MKN-45) cancer cells [135139]
Brefeldin A (BFA) ROS↑, IRE1α ↑, PERK ↑, XBP1↑; GRP78↑ CHOP↑ Ovarian (OVCAR-3); lung (A549); colorectal (colo 205); breast (MDA-MB-231) cancer cells [140142]
A-tocopheryl succinate SGC-7901 GRP78/BiP ↑, CHOP ↑ [143]
Verrucarin A GRP78/BiP ↑, p-PERK ↑, p-eIF2α ↑, CHOP ↑ Hep3B, HepG2 [144]
Vitamin E succinate GRP78/BiP ↑, GRP94 ↓, PERK ↑, ATF4 ↑, ATF6 ↑, XBP1 ↑, CHOP ↑ SGC-7901 [145]
Ultrafine p-eIF2α ↑, GRP78/BiP ↑ SNU-484 [146]
Zerumbone ATF4 ↑, CHOP ↑, GRP78/BiP ↑, p-PERK ↑, PERK ↑ eIF2α ↑, p-eIF2α HCT116-p53null, SW480, PC3 [68, 147]